Organogenesis
ORGO | NASDAQ
$0.80
-$0.01 (-1.25%)
At close: Nov 16, 2026, 4:00 PM ET
$0.80
$0.00 (+0.39%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-1.25%
(1D)No price chart data available for 1D timeframe.
Rating
33.8
Fundamentals Weak
Market Sentiment Neutral
Moat Narrow
Sector Rank #689/1021 (Top 67%)
Key Statistics
Market Data
Market Cap $104.24M
1D Range
0.78 0.83
52W Range
0.76 5.99
Valuation (TTM)
PE -0.67
PB 0.87
EV/EBITDA -2.48
Valuation (NTM)
Forward PE 8.55
Forward PEG 0.00
Price Target $2.50
Cash Flow
FCF Yield -0.1%
SBC Adj. FCF Yield -13.3%
SBC Impact -21590.6%
Margins
Gross Margin 62.0%
Operating Margin -22.8%
FCF Margin 0.0%
Growth (CAGR)
Revenue 3Y | 5Y -7.8% |
-4.7%
Dil EPS 3Y | 5Y -125.0% |
-215.3%
FCF 3Y | 5Y -12.4% |
-68.3%
Returns
ROA -38.3%
ROE -46.3%
ROIC -24.3%
Financial Health
Net Debt
$43.19M
Current Ratio 3.32
Interest Coverage -1,316.15
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Organogenesis Holdings Inc. is a U.S.-based regenerative medicine firm that specializes in creating, producing, and marketing innovative therapies for advanced wound management, as well as surgical an...
Sector Healthcare
Employees 854
IPO Date Jan 5, 2017
Website organogenesis.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 5, 2026
EPS
-$0.25
Miss -42.86%
YoY:
-238.89% REV
$45.5M
Miss -12.67%
YoY:
-69.84%Next Earnings
Mar 4, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
2
Consensus
Hold
Price Target
$2.50
Upside
+212.50%
Buy (1)
Hold (1)
Sell (0)
Add to Watchlist
Select watchlists to add or remove ORGO